BeOne Medicines (ONC) Other Non-Current Assets (2015 - 2026)

BeOne Medicines (ONC) has reported Other Non-Current Assets for 12 consecutive years, with $104.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 30.45% year-over-year to $104.2 million; the TTM figure through Mar 2026 stood at $104.2 million (down 30.45% YoY), while the FY2025 annual figure was $102.4 million, down 36.18% from the prior year.
• Other Non-Current Assets advanced to $104.2 million in Q1 2026 per ONC's latest filing, from $102.4 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $201.2 million in Q3 2024 and bottomed at $3.9 million in Q2 2022.
• Historically, Other Non-Current Assets has averaged $121.2 million across 5 years, with a median of $140.6 million in 2022.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets plunged 60.32% — and 2024, when it soared 3910.09%.
• BeOne Medicines' Other Non-Current Assets stood at $75.1 million in 2022, then jumped by 66.89% to $125.4 million in 2023, then climbed by 28.02% to $160.5 million in 2024, then sank by 36.18% to $102.4 million in 2025, then increased by 1.78% to $104.2 million in 2026.
• Business Quant data shows ONC's Other Non-Current Assets at $104.2 million in Q1 2026, $102.4 million in Q4 2025, and $136.2 million in Q3 2025.